Harmonic Bio News Today

SAN FRANCISCO, May 28, 2024 -- Third Harmonic Bio, Inc. , a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the

U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24 Strong financial position with cash and cash equivalents totaling $269.1 million as of December 31, 2023 SAN...

Third Harmonic Bio, Inc. (NASDAQ: THRD) shares cleared breakeven Tuesday, as the biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported financial results for the fourth quarter ended December ...

Check out this week’s medical marketing news, people on the move and industry chatter.

By Dean Seal Third Harmonic Bio has hired a former group vice president at Horizon Therapeutics to be its next chief financial officer. The biopharmaceutical...

THRD | Complete Third Harmonic Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

By Colin Kellaher Third Harmonic Bio on Tuesday said two top executives are leaving their posts at the biopharmaceutical company. The San Francisco company...